Visible effects of rapamycin (sirolimus) on human skin explants in vitro

Archives of Dermatological Research

Volumn 305, Issue 2, 2013, Pages 163-171

  Peramo, Antonio ^a   Marcelo, Cynthia L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

E cadherin; Involucrin; Keratinocytes; Rapamycin; Skin culture

Indexed keywords

CASPASE 3; INVOLUCRIN; KI 67 ANTIGEN; RAPAMYCIN; UVOMORULIN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG MECHANISM; EXPLANT; HISTOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SKIN CELL; SKIN CULTURE;

ADMINISTRATION, TOPICAL; APOPTOSIS; CADHERINS; CASPASE 3; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; KERATINOCYTES; KI-67 ANTIGEN; ORGAN CULTURE TECHNIQUES; PROTEIN PRECURSORS; SIROLIMUS; SKIN; SKIN DISEASES; SKIN TRANSPLANTATION; TISSUE ENGINEERING;

EID: 84878849124     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-012-1288-3     Document Type: Article

References (40)

1. Ameglio F, Bonifati C, Fazio M, Mussi A, Trento E, Cordial Fei P, Donati P, Pimpinelli F, D'Auria L, Carducci M (1997) Interleukin-11 production is increased in organ cultures of lesional skin of patients with active plaque-type psoriasis as compared with nonlesional and normal skin. Similarity to interleukin-1 beta, interleukin-6 and interleukin-8. Arch Dermatol Res 289:399-403
2. Bacqueville D, Mavon A (2008) Caspase-3 activation and DNA damage in pig skin organ culture after solar irradiation. Photochem Photobiol 84:1164-1171
3. Bansbach C, Wancio D, Caccese RG, Shen CF, Sehgal SN (1993) Rapamycin's inhibition of thymocyte proliferation, unlike that of cyclosporin A or prednisolone, is not associated with cytotoxicity. Ann N Y Acad Sci 685:114-116
4. Bridges D, Fisher K, Zolov SN, Xiong T, Inoki K, Weisman LS, Saltiel AR (2012) Rab5 proteins regulate activation and localization of target of rapamycin complex 1. J Biol Chem 287:20913-20921
5. Butzal M, Loges S, Schweizer M, Fischer U, Gehling UM, Hossfeld DK, Fiedler W (2004) Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro. Exp Cell Res 300:65-71
6. Calne RY, Lim S, Samaan AD, Collier STJ, Pollard SG, White DJG, Thiru S (1989) Rapamycin for immunosuppression in organ allografting. Lancet 334:227
7. Campistol JM, de Fijter JW, Flechner SM, Langone A, Morelon E, Stockfleth E (2010) mTOR inhibitor-associated dermatologic and mucosal problems. Clin Transpl 24:149-156
8. Calautti E, Li J, Saoncella S, Brissete JL, Goetinck PF (2005) Phosphoinositide 3-kinase signalling to Akt promotes keratinocyte differentiation versus death. J Biol Chem 280:32856-32865
9. Canning MT, Brown DA, Yarosh DB (2003) A bicyclic monoterpene diol and UVB stimulate BRCA1 phosphorylation in human keratinocytes. Photochem Photobiol 77:46-51
10. Chen S, Nakahara T, Uchi H, Takeuchi S, Takahara M, Kido M, Dugu L, Tu Y, Moroi Y, Furue M (2009) Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease. Br J Dermatol 161:357-363
11. Duncan JI (1994) Differential inhibition of cutaneous T-cell mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506 and rapamycin. J Invest Dermatol 102:84-88
12. Engelhart K, El Hindi T, Biesalski HK, Pfitzner I (2005) In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models. Arch Dermatol Res 297:1-9
13. Ferrer IR, Araki K, Ford ML (2011) Paradoxical aspects of rapamycin immunobiology in transplantation. Am J Transpl 11:654-659
14. Fried L, Kirsner RS, Bhandarkar S, Arbirser JL (2008) Efficacy of rapamycin in scleroderma: a case study. Lymphat Res Biol 6:217-219
15. Grando SA, Laquer VT, Le HM (2011) Sirolimus for acute pemphigus vulgaris: a case report and discussion of dualistic action providing for both immunosuppression and keratinocyte protection. J Am Acad Dermatol 65:684-686
16. Hickerson RP, Leake D, Pho LN, Leachman SA, Kaspar RL (2009) Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients. J Dermatol Sci 56:82-88
17. Inoki K, Ouyang H, Li Y, Guan KL (2005) Signaling by target of rapamycin proteins in cell growth control. Microbiol Mol Biol Rev 69:79-100
18. Izumi K, Inoki K, Fujimori Y, Marcelo CL, Feinberg SE (2009) Pharmacological retention of oral mucosa progenitor/stem cells. J Dent Res 88:1113-1118
19. Janes SM, Ofstad TA, Campbell DH, Eddaoudi A, Warnes G, Davies D, Watt FM (2009) PI3-kinase-dependent activation of apoptotic machinery occurs on commitment of epidermal keratinocytes to terminal differentiation. Cell Res 19:328-339
20. Javier AF, Bata-Csorgo Z, Ellis CN, Kang S, Voorhes JJ (1997) Rapamycin (Sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells. J Clin Invest 99:2094-2099
21. Kleszczynski k, Fischer TW (2012) Development of a short-term human full-thickness skin organ culture model in vitro under serum-free conditions. Arch Dermatol Res. doi: 10.1007/s00403-012-1239-z
22. Kooy AJ, Tank B, de Jong AA, Vuzevski VD, van der Kwast TH, van Joost T (1999) Expression of E-cadherin, alpha- & beta-catenin, and CD44V6 and the subcellular localization of E-cadherin and CD44V6 in normal epidermis and basal cell carcinoma. Hum Pathol 30:1328-1335
23. Lebonvallet N, Jeanmaire C, Danoux L, Sibille P, Pauly G, Misery L (2010) The evolution and use of skin explants: potential and limitations for dermatological research. Eur J Dermatol 20:671-684
24. Loewe R, Oble DA, Valero T, Zukerberg L, Mihm MC Jr, Nelson JS (2010) Stem cell marker upregulation in normal cutaneous vessels following pulsed-dye laser exposure and its abrogation by concurrent rapamycin administration: implications for treatment of port-wine stain birthmarks. J Cutan Pathol 37:76-82
25. Luan FL, Hojo M, Maluccio M, Yamaji K, Suthanthiran M (2002) Rapamycin blocks tumor progression unlinking immunosuppression from antitumor efficacy. Transplantation 73:1565-1572
26. Ma J, Meng Y, Kwiatkowski DJ, Chen X, Peng H, Sun Q, Zha X, Wang F, Wang Y, Jing Y, Zhang S, Chen R, Wang L, Wu E, Cai G, Malinowska-Kolodziej I, Liao Q, Liu Y, Zhao Y, Sun Q, Xu K, Dai J, Han J, Wu L, Zhao RC, Shen H, Zhang H (2010) Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. J Clin Invest 120:103-114
27. Mass P, Hoffmann K, Gambichler T, Altmeyer P, Mannherz HG (2003) Premature keratinocyte death and expression of marker proteins of apoptosis in human skin after UVB exposure. Arch Dermatol Res 295:71-79
28. Micozkadioglu H, Koc Z, Ozelsancak R, Yildiz I (2010) Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient. Ren Fail 32:1233-1236
29. Ong CT, Khoo YT, Mukhopadhyay A, Do DV, Lim IJ, Aalami O, Phan TT (2007) mTOR as a potential therapeutic target for treatment of keloids and excessive scars. Exp Dermatol 16:394-404
30. Ormerod AD, Shah SA, Copeland P, Omar G, Winfield A (2005) Treatment of psoriasis with topical sirolimus: preclinical development and a randomized, double-blind trial. Br J Dermatol 152:758-764
31. Paghdal KV, Schwartz RA (2007) Sirolimus (rapamycin): from the soil of Easter Island to a bright future. J Am Acad Dermatol 57:1046-1050
32. Peramo A, Marcelo CL, Goldstein SA, Martin DC (2009) Novel organotypic cultures of human skin explants with an implant-tissue biomaterial interface. Ann Biomed Eng 37:401-409
33. Peramo A, Marcelo CL, Goldstein SA, Martin DC (2010) Improved preservation of the tissue surrounding percutaneous devices by hyaluronic acid and dermatan sulfate in a human skin explant model. Ann Biomed Eng 38:1098-1110
34. Pretel M, Espana A, Marquina M, Pelacho B, Lopez-Picazo JM, Lopez-Zabalza MJ (2009) An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris. Exp Dermatol 18:771-780
35. Raimondi AR, Molinolo A, Gutkind JS (2009) Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model. Cancer Res 69:4159-4166
36. Saggar S, Zeichner JA, Brown TT, Phelps RG, Cohen SR (2008) Kaposi's sarcoma resolves after sirolimus therapy in a patient with Pemphigus Vulgaris. Arch Dermatol 144:654-657
37. Thrash B, Menges CW, Pierces RH, McCance DJ (2006) AKT1 provides an essential survival signal for differentiation and stratification of primary human keratinocytes. J Biol Chem 281:12155-12162
38. Toso C, Patel S, Asthana S, Kawahara T, Girgis S, Kneteman NN, Shapiro AMJ, Bigam DL (2010) The impact of sirolimus on hepatocyte proliferation after living donor liver transplantation. Clin Transpl 24:695-700
39. Wu MJ, Wen MC, Chiu YT, Chiou YY, Shu KH, Tang MJ (2006) Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int 69:2029-2036
40. Young CN, Koepke JI, Terlecky LJ, Borkin MS, Boyd Savoy L, Terlecky SR (2008) Reactive oxygen species in tumor necrosis factor-a-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease. J Invest Dermatol 128:2606-2614